# Nanova Biomaterials Inc – FDA Inspection, Feb 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/nanova-biomaterials-inc/6b433a4d-6b7a-421e-961f-0ac8398d6685
Source feed: FDA_Inspections

> FDA inspection 1261208 of Nanova Biomaterials Inc, February 14, 2025. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 820. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261208
- Company Name: Nanova Biomaterials Inc
- Inspection Date: 2025-02-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Center: Medical Devices & Rad Health
- Office Name: Kansas City District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1035830 - 2017-12-08](https://www.keypedia.com/records/fda_inspections/nanova-biomaterials-inc/80cfe360-e2fb-47c3-aa27-ee9f7e0bbd2a)
- [FDA Inspection 1034225 - 2017-12-08](https://www.keypedia.com/records/fda_inspections/nanova-biomaterials-inc/5f20396e-ad48-41ad-9305-3c8e63e0bdd3)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/clifford-f-long/846e5a0c-cb7c-421c-86aa-be9fddfbaaba)

Company: https://www.keypedia.com/companies/nanova-biomaterials-inc/01c88cc2-db44-4bf8-8c77-8581d172aa0f

Office: https://www.keypedia.com/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79
